Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38: A Randomized Clinical Trial

NCT07342296 is registered in ClinicalTrials.gov with Danish Headache Center as lead sponsor.

NCT NCT07342296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07342296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38: A Randomized Clinical Trial
Lead sponsor
Danish Headache Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
December 30, 2026
Enrollment
21 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

migraine aura, migraine with aura